Exploring the potential of short-acting immune checkpoint blockers in the therapy of sepsis

• Unité de recherche: INNOSUISSE
• Numéro de projet: 118.041 IP-LS
• Titre du projet anglais: Exploring the potential of short-acting immune checkpoint blockers in the therapy of sepsis

Mots-clé (Anglais)

Life sciences, Human medicine

Résumé des résultats (Abstract) (Anglais)

Sepsis is a life-threatening disease lacking effective treatment options. Based on our scientific discovery, we have developed an innovative therapy that targets the dysfunctional host response. This project aims to validate our lead compound and establish its efficacy in preclinical sepsis models.